sample	tissue	condition	fpkm
SRR886457	512 cell	4-thio-UTP metabolic labeling	13.1918
SRR800043	sphere stage	normal	4.45124
SRR886456	256 cell	4-thio-UTP metabolic labeling	3.4355800000000003
SRR800046	sphere stage	5azaCyD treatment	3.07144
SRR748491	germ ring	normal	2.8993700000000002
SRR800049	sphere stage	control treatment	2.8307900000000004
SRR1021213	sphere stage	normal	1.62176
SRR372791	dome	normal	0.860007
SRR1021215	sphere stage	Mzeomesa	0.5682189999999999
SRR1205157	5dpf	transgenic sqET20 and neomycin treated 1h and GFP+	0.482972
SRR1621206	embryo	normal	0.40119299999999997
ERR145646	skeletal muscle	32 degree_C to 27 degree_C	0.298029
SRR372793	shield	normal	0.272859
SRR516125	skin	male and 3.5 year	0.190554
SRR1035237	liver	transgenic UHRF1	0.184619
SRR527840	24hpf	normal	0.14122200000000001
SRR1205169	5dpf	transgenic sqET20 and neomycin treated 5h and GFP+	0.12123900000000001
SRR1167752	embryo	normal	0.104244
ERR145631	skeletal muscle	32 degree_C to 16 degree_C	0.0933542
ERR594416	retina	transgenic flk1	0.0762488
SRR797911	embryo	prdm1-/-	0.07478969999999999
SRR1523214	embryo	glut12 morpholino	0.0739227
SRR658541	6 somite	normal	0.0694173
SRR630463	5 dpf	normal	0.0625188
ERR594418	retina	transgenic flk1 and develop tumors	0.0618741
SRR797917	embryo	pbx2/4-MO and prdm1-/-	0.0573033
SRR1205166	5dpf	transgenic sqET20 and neomycin treated 3h	0.05645119999999999
SRR1205172	5dpf	transgenic sqET20 and neomycin treated 5h	0.0550298
SRR519727	6 dpf	FETOH treatment	0.0480043
SRR519737	2 dpf	VD3 treatment	0.042476400000000004
SRR797908	embryo	normal	0.039499
SRR519717	2 dpf	FETOH treatment	0.026698799999999998
SRR519732	7 dpf	FETOH treatment	0.00961493
SRR519752	7 dpf	VD3 treatment	0.00758544
SRR519747	6 dpf	VD3 treatment	0.00749153